Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020
Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 News provided by Share this article Share this article SAN DIEGO, March 11, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced program updates and financial results for the fourth quarter and full year ended December 31, 2020. "2020 was a transformative year for Poseida, as we completed ...
Source: prnewswire.com